Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00524472 · ClinicalTrials.gov registry record · NA
Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 1,439
- Enrollment target
NCT00524472 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 1,439 participants.
The verdict
NCT00524472, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,439 participants
- Enrollment target
Study Summary
Patients undergoing cardiac surgery will be randomized into one of two groups. Group A will be administered insulin using the hyperinsulinemic-normoglycemic clamp to normalize blood glucose levels intra-operatively. Group B will be administered insulin at the standard of care levels established by the participating institution. Patients will be followed at 10 days, 15 days and one year post-operatively.
Interventions
- OTHER Hyperinsulinemic-normoglycemic clamp
- OTHER insulin at the standard of care levels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,439 participants |
| Start Date | 2007-07 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00524472
The ClinicalTrials.gov registry entry for NCT00524472 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,439 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hyperinsulinemic-normoglycemic clamp is the first listed.
NCT00524472 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00524472 about?
NCT00524472 is a clinical study titled "Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery". Patients undergoing cardiac surgery will be randomized into one of two groups. Group A will be administered insulin using the hyperinsulinemic-normoglycemic clamp to normalize blood glucose levels intra-operatively. Group B will be administered insulin at the standard of care levels established by t...
What is the current status of trial NCT00524472?
This trial is currently completed. It is a NA study. The enrollment target is 1,439 participants. The study started on 2007-07. Estimated completion is 2015-04.
What interventions are being tested in trial NCT00524472?
The interventions under investigation include: Hyperinsulinemic-normoglycemic clamp (OTHER), insulin at the standard of care levels (OTHER).
Who is sponsoring clinical trial NCT00524472?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.